Results 101 to 110 of about 7,599 (172)

Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14. [PDF]

ACS Chem Biol, 2017
Schuller M, Riedel K, Gibbs-Seymour I, Uth K, Sieg C, Gehring AP, Ahel I, Bracher F, Kessler BM, Elkins JM, Knapp S.   +10 more
europepmc   +1 more source

SLFN11 expression as a marker of small cell lung cancer vulnerability to combined PARP inhibitors and immune checkpoint inhibitors during maintenance. [PDF]

J Thorac Dis
Pujol JL.
europepmc   +1 more source

Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats. [PDF]

Respir Res, 2013
Si MK, Mitaka C, Tulafu M, Abe S, Kitagawa M, Ikeda S, Eishi Y, Kurata S, Tomita M.   +8 more
europepmc   +1 more source

Comment on "<i>PARP-1</i> rs1136410 Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis of Cancer-Type and Ethnic-Specific Associations". [PDF]

Medeni Med J
Alkan O, Nazli I, Basgoze A.
europepmc   +1 more source

Studies on poly(adenosine diphosphate ribose). IX. Direction of hydrolysis of poly(adenosine diphosphate ribose) by rat liver phosphodiesterase.

The Journal of biological chemistry, 1971
H, Matsubara, S, Hasegawa, S, Fujimura, T, Shima, T, Sugimura   +4 more
openaire   +1 more source

Poly(ADP-ribose) (PAR) exhibits ion-dependent structural properties distinct from RNA. [PDF]

Nucleic Acids Res
Baidya L, Zhang H, Nguyen HT.
europepmc   +1 more source

Studies on poly (adenosine diphosphate ribose). V. Mechanism of hydrolysis of poly (adenosine diphosphate ribose) by snake venom phosphodiesterase.

The Journal of biological chemistry, 1970
H, Matsubara, S, Hasegawa, S, Fujimura, T, Shima, T, Sugimura   +4 more
openaire   +1 more source

POLY ADENOSINE DIPHOSPHATE RIBOSE SYNTHESIS AND NICOTINAMIDE ADENINE DINUCLEOTIDE TRANSGLYCOSIDASES

THE JOURNAL OF VITAMINOLOGY, 1968
NISHIZUKA, Y., UEDA, K., NAKAZAWA, K., REEDER, R. H., HONJO, T., HAYAISHI, O.   +5 more
openaire   +3 more sources

Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by <i>BRCA</i> status: a retrospective cohort study. [PDF]

ESMO Real World Data Digit Oncol
Zucker K, Pickwell-Smith B, Samani A, Sujenthiran A, Pittell H, Mpofu P, Hall G.   +6 more
europepmc   +1 more source